PER 1.23% 8.0¢ percheron therapeutics limited

next announcement and likely content, page-132

  1. 1,659 Posts.
    lightbulb Created with Sketch. 1

    ...itsagas

    ...Ace and i are refering to another drug Mipomersen owned by ISIS...

    ...ATL1103 is IMO at least 3 years from final phase 3 clinical trials...

    ..IMO a good estimate given these types of antisence drugs timeline is for 2 and half years per phase trial...

    ...so once the phase 1 trial is complted by end year, then you are looking approx 5 more years before both phase 2 and 3 are comlete, at the earliest i would say 4 years...

    ...Its years away from any possible cashflow but DYOR...

    ...RB
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.